Mechanisms of sympathetic restraint in human skeletal muscle during exercise: role of α-adrenergic and nonadrenergic mechanisms.


Journal

American journal of physiology. Heart and circulatory physiology
ISSN: 1522-1539
Titre abrégé: Am J Physiol Heart Circ Physiol
Pays: United States
ID NLM: 100901228

Informations de publication

Date de publication:
01 07 2020
Historique:
pubmed: 6 6 2020
medline: 7 10 2020
entrez: 6 6 2020
Statut: ppublish

Résumé

Sympathetic vasoconstriction is mediated by α-adrenergic receptors under resting conditions. During exercise, increased sympathetic nerve activity (SNA) is directed to inactive and active skeletal muscle; however, it is unclear what mechanism(s) are responsible for vasoconstriction during large muscle mass exercise in humans. The aim of this study was to determine the contribution of α-adrenergic receptors to sympathetic restraint of inactive skeletal muscle and active skeletal muscle during cycle exercise in healthy humans. In ten male participants (18-35 yr), mean arterial pressure (intra-arterial catheter) and forearm vascular resistance (FVR) and conductance (FVC) were assessed during cycle exercise (60% total peak workload) alone and during combined cycle exercise + handgrip exercise (HGE) before and after intra-arterial blockade of α- and β-adrenoreceptors via phentolamine and propranolol, respectively. Cycle exercise caused vasoconstriction in the inactive forearm that was attenuated ~80% with adrenoreceptor blockade (%ΔFVR, +81.7 ± 84.6 vs. +9.7 ± 30.7%;

Identifiants

pubmed: 32502375
doi: 10.1152/ajpheart.00208.2020
pmc: PMC7474447
doi:

Substances chimiques

Adrenergic alpha-Antagonists 0
Adrenergic beta-Antagonists 0
Propranolol 9Y8NXQ24VQ
Phentolamine Z468598HBV

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

H192-H202

Subventions

Organisme : HHS | National Institutes of Health (NIH)
ID : NIH 1F32HL1377285-0
Pays : International

Références

Am J Physiol Heart Circ Physiol. 2019 Aug 1;317(2):H243-H254
pubmed: 31149843
J Physiol. 2013 Jul 15;591(14):3637-49
pubmed: 23652594
J Physiol. 2017 Aug 1;595(15):5175-5190
pubmed: 28590059
Springerplus. 2015 Nov 19;4:707
pubmed: 26618096
Compr Physiol. 2015 Dec 15;6(1):303-29
pubmed: 26756634
J Physiol. 2002 May 1;540(Pt 3):1103-10
pubmed: 11986395
Hypertension. 2018 Jan;71(1):151-159
pubmed: 29084879
Acta Physiol Scand. 1977 Jul;100(3):288-97
pubmed: 920199
J Physiol. 2002 Nov 1;544(3):977-84
pubmed: 12411540
J Physiol. 2014 Nov 1;592(21):4775-88
pubmed: 25194040
J Physiol. 2016 Dec 15;594(24):7435-7453
pubmed: 27561916
Circulation. 2002 Sep 10;106(11):1349-54
pubmed: 12221051
J Vasc Res. 1996 Mar-Apr;33(2):124-31
pubmed: 8630345
Br J Pharmacol. 2008 Feb;153(4):831-9
pubmed: 18071295
J Physiol. 2004 May 1;556(Pt 3):1001-11
pubmed: 14990681
J Physiol. 2009 May 1;587(Pt 9):1989-2003
pubmed: 19307300
J Physiol. 1999 Jan 1;514 ( Pt 1):283-91
pubmed: 9831733
Exp Physiol. 2013 Apr;98(4):867-78
pubmed: 23261851
Am J Physiol Heart Circ Physiol. 2010 May;298(5):H1626-32
pubmed: 20173048
Circulation. 1961 Jul;24:76-81
pubmed: 13767236
Auton Neurosci. 2015 Dec;193:12-21
pubmed: 26299824
J Physiol. 2002 Jun 1;541(Pt 2):623-35
pubmed: 12042366
Am J Physiol. 1989 Sep;257(3 Pt 2):H866-72
pubmed: 2782443
J Appl Physiol (1985). 1993 Aug;75(2):663-7
pubmed: 8226466
J Physiol. 1902 May 28;28(3):220-31
pubmed: 16992618
Circulation. 1992 Dec;86(6):1789-99
pubmed: 1451251
J Physiol. 2008 Oct 15;586(20):4993-5002
pubmed: 18703581
J Physiol. 2008 Sep 1;586(17):4305-16
pubmed: 18617568
Am J Physiol Heart Circ Physiol. 2002 Dec;283(6):H2260-7
pubmed: 12388265
J Appl Physiol (1985). 1997 Nov;83(5):1575-80
pubmed: 9375322
J Appl Physiol (1985). 2003 Dec;95(6):2370-4
pubmed: 12923119
J Physiol. 2006 Dec 1;577(Pt 2):727-37
pubmed: 16973706
J Hypertens. 2016 Feb;34(2):266-73
pubmed: 26599223
J Physiol. 2012 Dec 15;590(24):6269-75
pubmed: 22988143
J Am Coll Cardiol. 2000 Oct;36(4):1233-8
pubmed: 11028476
Am J Physiol. 1991 Feb;260(2 Pt 2):H632-7
pubmed: 1996706
Am J Physiol Heart Circ Physiol. 2013 Jul 15;305(2):H163-72
pubmed: 23666670
J Appl Physiol (1985). 2003 Sep;95(3):953-9
pubmed: 12766177
Am J Physiol. 1999 Jul;277(1):H33-9
pubmed: 10409179
Microvasc Res. 1989 Mar;37(2):230-6
pubmed: 2725343
J Appl Physiol (1985). 2001 Jan;90(1):172-8
pubmed: 11133908
J Appl Physiol (1985). 2006 May;100(5):1563-8
pubmed: 16410381
J Physiol. 2018 Jun;596(12):2315-2332
pubmed: 29635787
Exerc Sport Sci Rev. 2001 Oct;29(4):159-63
pubmed: 11688788
J Physiol. 2003 Mar 15;547(Pt 3):971-6
pubmed: 12588902
Exp Physiol. 2011 Oct;96(10):1019-27
pubmed: 21784788
Hypertension. 2000 Jan;35(1 Pt 1):76-81
pubmed: 10642278
J Physiol. 2008 Jun 1;586(11):2753-66
pubmed: 18403425
J Physiol Sci. 2019 Jul;69(4):589-598
pubmed: 31054082
J Physiol. 1998 Dec 15;513 ( Pt 3):907-13
pubmed: 9824727
J Physiol. 2011 Mar 1;589(Pt 5):1209-20
pubmed: 21224235
Am J Physiol. 1992 Oct;263(4 Pt 2):H1078-83
pubmed: 1415755
J Physiol. 2012 May 1;590(9):2069-79
pubmed: 22351633
Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H144-9
pubmed: 15210450
J Appl Physiol (1985). 2002 May;92(5):2105-13
pubmed: 11960963
Circ Res. 1962 Sep;11:370-80
pubmed: 13981593
J Appl Physiol (1985). 2001 May;90(5):1855-9
pubmed: 11299277
J Appl Physiol (1985). 2007 Sep;103(3):969-78
pubmed: 17600155
Exp Physiol. 2014 Dec 1;99(12):1552-8
pubmed: 25192730
J Physiol. 2004 Jul 1;558(Pt 1):319-31
pubmed: 15121799
J Physiol. 2001 Nov 1;536(Pt 3):977-83
pubmed: 11691889
Med Sci Sports Exerc. 1989 Oct;21(5):581-5
pubmed: 2691819
Acta Physiol Scand. 1987 Dec;131(4):507-15
pubmed: 3442240
Auton Neurosci. 2011 Jul 5;162(1-2):89-93
pubmed: 21514900

Auteurs

Alexander B Hansen (AB)

Department of Sport Science, University of Innsbruck, Innsbruck, Austria.

Gilbert Moralez (G)

Department of Applied Clinical Research, University of Texas Southwestern Medical Center, Dallas, Texas.

Steven A Romero (SA)

University of North Texas Health Science Center, Fort Worth, Texas.

Christopher Gasho (C)

Division of Pulmonary and Critical Care, Department of Medicine, University of Loma Lida, Loma Lida, California.

Michael M Tymko (MM)

Centre of Heart, Lung, and Vascular Health, School of Health and Exercise Sciences, University of British Columbia-Okanagan, Kelowna, British Columbia, Canada.
Physical Activity and Diabetes Laboratory, Faculty of Kinesiology, Sport and Recreation, University of Alberta, Edmonton, Alberta, Canada.

Philip N Ainslie (PN)

Centre of Heart, Lung, and Vascular Health, School of Health and Exercise Sciences, University of British Columbia-Okanagan, Kelowna, British Columbia, Canada.

Florian Hofstätter (F)

Department of Sport Science, University of Innsbruck, Innsbruck, Austria.

Simon L Rainer (SL)

Department of Sport Science, University of Innsbruck, Innsbruck, Austria.

Justin S Lawley (JS)

Department of Sport Science, University of Innsbruck, Innsbruck, Austria.

Christopher M Hearon (CM)

Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Dallas, Dallas, Texas.
University of Texas Southwestern Medical Center, Dallas, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH